A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Aim ETF Prods Tr Allianzim Us stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 9,986 shares of AZAL stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,986
Previous 8,759 14.01%
Holding current value
$0
Previous $324,000 19.14%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
N/A
1,227 Added 14.01%
9,986 $386,000
Q2 2024

Jul 26, 2024

BUY
N/A
800 Added 10.05%
8,759 $324,000
Q4 2023

Feb 09, 2024

BUY
$30.08 - $33.64 $239,406 - $267,740
7,959 New
7,959 $267,000
Q1 2023

May 11, 2023

SELL
$27.54 - $29.57 $214,206 - $229,995
-7,778 Reduced 2.28%
332,712 $9.73 Million
Q4 2022

Feb 08, 2023

BUY
$26.95 - $28.83 $124,104 - $132,762
4,605 Added 1.37%
340,490 $9.43 Million
Q3 2022

Oct 17, 2022

BUY
$26.6 - $29.25 $8.93 Million - $9.82 Million
335,885 New
335,885 $0

Others Institutions Holding AZAL

About AIM ETF PRODS TR ALLIANZIM US


  • Ticker AZAL
  • Sector Technology
More about AZAL
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.